一名癌症幸存者敦促纽约立法者将医疗补助的覆盖面保留在生物标志测试上,以确保公平、有效的癌症护理。 A cancer survivor urges New York lawmakers to keep Medicaid coverage for biomarker testing to ensure equitable, effective cancer care.

2026年2月23日的一封信反对州长Kathy Hoghul关于取消纽约生物标志测试医疗补助覆盖面的提议, A letter dated February 23, 2026, opposes Governor Kathy Hochul’s proposal to remove Medicaid coverage for biomarker testing in New York, warning it could limit access to precision medicine, deepen health disparities, and increase long-term healthcare costs. 作者是癌症幸存者,强调生物标志测试以证据为基础,对于有效、个性化治疗至关重要。 The author, a cancer survivor, stresses that biomarker testing is evidence-based and vital for effective, individualized treatment. 它们敦促立法者保持覆盖,以确保公平的护理。 They urge lawmakers to maintain coverage to ensure equitable care. 文章还提到了对NASCAR传奇人物戴尔·恩哈特（Dale Earnhardt Sr.）和本地事故的致敬，但重点放在医疗政策上。 The piece also notes tributes to NASCAR legend Dale Earnhardt Sr. and local accidents, but centers on healthcare policy.